Nanomedicine and risk: further perspectives.
The first article in this new series on nanomedicine, advocated the need for more risk research in the field of medical nanotechnology. Here, some further aspects of risk at the nanoscale are considered and suggestions are made on where this risk effort should be focused.
Moore
Richard
R
The Institute of Nanotechnology, Stirling, UK. richard.moore@nano.org.uk
D004864:Equipment and Supplies / Q000009:adverse effects*; D005549:Foreign-Body Reaction / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D050997:Nanomedicine / Q000379:methods*; D049329:Nanostructures / Q000009:adverse effects*; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors